Effect of different subanesthetic dose of esmketamine on emergence agitation in children undergoing tonsillectomy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300071495

Enrollment

Unknown

Registered

2023-05-16

Start date

2023-05-25

Completion date

Unknown

Last updated

2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

emergence agitation

Interventions

Group A:0.25mg esketamine

Group B:0.5mg esketamine

Eligibility

Sex/Gender

All

Age

3 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Age 3 to 12 years, weight 15 to 50 kg; 2. no contraindications to general anaesthesia; 3. ASA grades I to II;

Exclusion criteria

Exclusion criteria: 1. Mental abnormalities of cognition, intellectual dysplasia, hyperactivity or autism; 2. used psychotropic drugs in the last two months; 3. had history of severe allergy to drugs; 4. guardian of child refused to participate in the trial

Design outcomes

Primary

Measure	Time frame
incidence of emergence agitation;	—

Secondary

Measure	Time frame
extubation time;PACU residence time;FLACC pain score;	—

Countries

China

Contacts

Public Contactgaomaoli

Ya'an People's Hospital

973796256@qq.com+86 183 8353 9982

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026